🇺🇸 FDA

Drug profile · INN

erdafitinib

BALVERSA

FDA: approved EMA: approved L01EN01
US status
approved
Patents linked
0
News articles
0

Quick answer

erdafitinib (BALVERSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN erdafitinib
Brand BALVERSA
Route ORAL
Formulation TABLET
ATC code L01EN01

Frequently asked questions

What is erdafitinib?

erdafitinib (BALVERSA) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for erdafitinib?

BALVERSA is a marketed brand name for erdafitinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of erdafitinib?

erdafitinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.